Financial results - MEDIMPACT SRL

Financial Summary - Medimpact Srl
Unique identification code: 15255428
Registration number: J40/3121/2003
Nace: 8622
Sales - Ron
189.180
Net Profit - Ron
10.297
Employee
3
The most important financial indicators for the company Medimpact Srl - Unique Identification Number 15255428: sales in 2023 was 189.180 euro, registering a net profit of 10.297 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Medimpact Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 139.592 156.051 162.524 161.424 157.807 156.761 143.552 163.310 173.637 189.180
Total Income - EUR 139.600 156.063 162.529 161.659 157.809 169.423 143.760 163.311 179.722 189.182
Total Expenses - EUR 154.912 145.359 156.337 147.848 138.474 165.523 128.081 162.960 144.356 177.276
Gross Profit/Loss - EUR -15.312 10.703 6.192 13.811 19.335 3.900 15.679 350 35.366 11.905
Net Profit/Loss - EUR -15.312 10.703 6.192 10.407 17.761 2.206 14.241 -1.250 33.605 10.297
Employees 7 10 11 0 9 8 5 0 5 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 9.3%, from 173.637 euro in the year 2022, to 189.180 euro in 2023. The Net Profit decreased by -23.206 euro, from 33.605 euro in 2022, to 10.297 in the last year.

Check the financial reports for the company - Medimpact Srl

Rating financiar

Financial Rating -
Medimpact Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Medimpact Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medimpact Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Medimpact Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medimpact Srl - CUI 15255428

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 22.386 11.134 5.317 1.687 33.925 23.516 24.648 26.361 18.398 15.024
Current Assets 37.785 52.802 47.462 50.654 44.538 57.033 52.330 37.509 44.089 44.512
Inventories 90 0 0 526 517 507 497 486 0 0
Receivables 20.847 18.274 36.443 27.086 25.652 38.747 42.253 31.290 30.645 38.770
Cash 16.847 34.528 11.019 23.042 18.369 17.779 9.581 5.733 13.445 5.742
Shareholders Funds 42.640 53.699 16.839 18.055 32.142 29.289 22.302 4.405 33.654 43.849
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 17.531 10.237 35.940 34.286 46.321 51.260 54.676 59.465 28.876 15.830
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 44.512 euro in 2023 which includes Inventories of 0 euro, Receivables of 38.770 euro and cash availability of 5.742 euro.
The company's Equity was valued at 43.849 euro, while total Liabilities amounted to 15.830 euro. Equity increased by 10.297 euro, from 33.654 euro in 2022, to 43.849 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Medimpact Srl

Comments - Medimpact Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.